Literature DB >> 36129636

Single-cell profile of tumor and immune cells in primary breast cancer, sentinel lymph node, and metastatic lymph node.

Ning Liao1, Cheukfai Li2, Li Cao2, Yanhua Chen3, Chongyang Ren2, Xiaoqing Chen4, Hsiaopei Mok2, Lingzhu Wen2, Kai Li2, Yulei Wang2, Yuchen Zhang2, Yingzi Li2, Jiaoyi Lv2, Fangrong Cao2, Yuting Luo2, Hongrui Li3, Wendy Wu5, Charles M Balch6, Armando E Giuliano7.   

Abstract

PURPOSE: Little is known about the host-tumor interaction in the lymph-node basin at a single cell level. This study examines single cell sequences in breast cancer nodal metastases of a patient with triple-negative breast cancer.
METHODS: The primary breast tumor, sentinel lymph node, an adjacent lymph node with metastatic involvement and a clinically normal-appearing lymph node were collected during surgery. Single-cell sequencing was performed on all four specimens.
RESULTS: 14,016 cells were clustered into 6 cell subpopulations. Cancer cells demonstrated the molecular characteristics of TNBC basal B subtype and highly expressed genes in the MAPK signaling cascade. Tumor-associated macrophages regulated antigen processing and presentation and other immune-related pathways to promote tumor invasion. CD8 + and CD4 + T lymphocytes concentrated more in sentinel lymph node and mainly stratified into two transcriptional states. The immune-cell amount variation among primary tumor, sentinel and normal lymph nodes showed a similar tendency between the sc-RNA-seq profile of TNBC samples and a previous reported bulk RNA-seq profile of a breast cancer cohort, including all four breast cancer subtype samples. DISCUSSION: Single-cell sequencing analysis suggested that the sentinel lymph node was the initial meeting site of tumor infiltration and immune response, where partial T lymphocytes perform anti-tumor activity, while other T cells exhibit an exhausted state. We proposed a molecular explanation to the well-established clinical principle that the 5-year and 10-year survival outcomes were noninferior between SLND and ALND.
© 2022. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.

Entities:  

Keywords:  Breast cancer; Immune response; Sentinel lymph node; sc-RNA-seq

Year:  2022        PMID: 36129636     DOI: 10.1007/s12282-022-01400-x

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   3.307


  44 in total

1.  The evolution of sentinel node biopsy for breast cancer: Personal experience.

Authors:  Armando E Giuliano
Journal:  Breast J       Date:  2019-12-26       Impact factor: 2.431

2.  Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.

Authors:  David N Krag; Stewart J Anderson; Thomas B Julian; Ann M Brown; Seth P Harlow; Joseph P Costantino; Takamaru Ashikaga; Donald L Weaver; Eleftherios P Mamounas; Lynne M Jalovec; Thomas G Frazier; R Dirk Noyes; André Robidoux; Hugh Mc Scarth; Norman Wolmark
Journal:  Lancet Oncol       Date:  2010-10       Impact factor: 41.316

3.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

4.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

5.  NCCN Guidelines® Insights: Breast Cancer, Version 4.2021.

Authors:  William J Gradishar; Meena S Moran; Jame Abraham; Rebecca Aft; Doreen Agnese; Kimberly H Allison; Sarah L Blair; Harold J Burstein; Chau Dang; Anthony D Elias; Sharon H Giordano; Matthew P Goetz; Lori J Goldstein; Sara A Hurvitz; Steven J Isakoff; Rachel C Jankowitz; Sara H Javid; Jairam Krishnamurthy; Marilyn Leitch; Janice Lyons; Jennifer Matro; Ingrid A Mayer; Joanne Mortimer; Ruth M O'Regan; Sameer A Patel; Lori J Pierce; Hope S Rugo; Amy Sitapati; Karen Lisa Smith; Mary Lou Smith; Hatem Soliman; Erica M Stringer-Reasor; Melinda L Telli; John H Ward; Kari B Wisinski; Jessica S Young; Jennifer L Burns; Rashmi Kumar
Journal:  J Natl Compr Canc Netw       Date:  2021-05-01       Impact factor: 11.908

6.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

7.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Authors:  Armando E Giuliano; Karla V Ballman; Linda McCall; Peter D Beitsch; Meghan B Brennan; Pond R Kelemen; David W Ollila; Nora M Hansen; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow
Journal:  JAMA       Date:  2017-09-12       Impact factor: 56.272

Review 8.  Improved axillary staging of breast cancer with sentinel lymphadenectomy.

Authors:  A E Giuliano; P S Dale; R R Turner; D L Morton; S W Evans; D L Krasne
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

9.  Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer.

Authors:  Woosung Chung; Hye Hyeon Eum; Hae-Ock Lee; Kyung-Min Lee; Han-Byoel Lee; Kyu-Tae Kim; Han Suk Ryu; Sangmin Kim; Jeong Eon Lee; Yeon Hee Park; Zhengyan Kan; Wonshik Han; Woong-Yang Park
Journal:  Nat Commun       Date:  2017-05-05       Impact factor: 14.919

10.  Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq.

Authors:  Mihriban Karaayvaz; Simona Cristea; Shawn M Gillespie; Anoop P Patel; Ravindra Mylvaganam; Christina C Luo; Michelle C Specht; Bradley E Bernstein; Franziska Michor; Leif W Ellisen
Journal:  Nat Commun       Date:  2018-09-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.